Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.70 |
| ▸ | HTT | P42858 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 5/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | DRD2 | P14416 | 2/20 | 0.52 |
| ▸ | DRD4 | P21917 | 2/20 | 0.52 |
| ▸ | DRD3 | P35462 | 2/20 | 0.52 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18886833 | 1.00 | HSD17B10 (0.70) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| SCHEMBL18886836 | 0.88 | ALDH1A1 (0.57) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| SCHEMBL3282288 | 0.83 | ALDH1A1 (0.60) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| SCHEMBL31025931 | 0.83 | GPR17 (0.57) | HSD17B10HTTMAPTALOX15KDM4E | |
| SCHEMBL8523338 | 0.79 | ALDH1A1 (0.54) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| SCHEMBL6091612 | 0.77 | ALDH1A1 (0.56) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| SCHEMBL4530902 | 0.77 | KDM4E (0.52) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| SCHEMBL30794481 | 0.77 | ALDH1A1 (0.49) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL4525276 | 0.76 | KDM4E (0.51) | HSD17B10HTTMAPTALDH1A1ALOX15 | |
| Hydrochloric Acid SCHEMBL4525491 | 0.76 | HTR2A (0.49) | HSD17B10HTTMAPTALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098047-A1 | Anti-Giardial Compounds | COMMW SCIENT IND RES ORG (AU) | 2026-04-09 | — | — | US | disclosed |
| EP-4660193-A1 | INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF | Korea Research Institute of Chemical Technology (KR) | 2025-12-10 | — | — | EP | disclosed |
| WO-2024162746-A1 | INDOLE COMPOUND DECOMPOSING IKZF2, AND USE THEREOF | 한국화학연구원 | 2024-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098047-A1 | Anti-Giardial Compounds | GNAO1, GPR6, MGAT3 | HSD17B10 2925/4885HTT 3585/4885MAPT 4805/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.